Recent NXL News
- Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23 • GlobeNewswire Inc. • 05/09/2024 12:30:00 PM
- Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements • GlobeNewswire Inc. • 04/25/2024 02:44:22 PM
- Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing • GlobeNewswire Inc. • 04/09/2024 12:30:00 PM
- Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device • GlobeNewswire Inc. • 04/04/2024 05:00:00 PM
- Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
- Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego • GlobeNewswire Inc. • 03/28/2024 12:30:00 PM
- Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology • GlobeNewswire Inc. • 03/14/2024 12:30:00 PM
- Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment” • GlobeNewswire Inc. • 03/13/2024 12:30:00 PM
- Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device • GlobeNewswire Inc. • 02/08/2024 01:30:00 PM
- Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System • GlobeNewswire Inc. • 01/23/2024 01:30:00 PM
- Nexalin Technology Unveils Next-Generation HALO™ Clarity • GlobeNewswire Inc. • 01/11/2024 01:30:00 PM
- Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression • GlobeNewswire Inc. • 12/18/2023 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:38:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 07:38:03 PM
- Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David Lasseter • GlobeNewswire Inc. • 10/25/2023 12:30:00 PM
- Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain Structures • GlobeNewswire Inc. • 10/16/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 04:09:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 04:08:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 04:07:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:18:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 07:07:19 PM
- Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms • GlobeNewswire Inc. • 08/07/2023 12:30:00 PM
- Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time • GlobeNewswire Inc. • 08/03/2023 12:30:00 PM
- Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies • GlobeNewswire Inc. • 07/26/2023 12:30:00 PM
- Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury • GlobeNewswire Inc. • 07/10/2023 12:30:00 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM